Skip to main content
. 2019 Feb 11;27(3):257–267. doi: 10.1111/wrr.12699

Table 2.

Outcome measures—intention‐to‐treat analyze

Outcome measure Flaminal® Forte (n = 41) Flamazine® (n = 48) p
Time to wound healing (days)*, median (range) 18 (8–49) 16 (7–48) 0.24†
Time to wound healing of nonoperated study area, median (range) 14.5 (8–27) 11 (7–29) 0.07†
Length of hospital stay, median (range) 16 (1–33) 17 (2–102) 0.79†
Need for operation, n (%) 21 (51) 24 (50) 0.91⊥
%TBSA of study area covered with skin graft, median (range) 1.5 (0–5) 0.9 (0–6) 0.20†
Complication after surgery, n 3/21 4/24 (not tested)

  • Hematoma

 1/21 0/24

  • Graft migration

 1/21 0/24

  • Graft loss

 1/21 3/24

  • Wound infection

 0/21 1/24

  • Allergic reaction

 0/21 1/24

  • Reoperation

 0/21 1/24
*

Defined as reepithelialization >95%.

†

Mann–Whitney test.

⊥

Chi‐square test.